Home > Healthcare & Medical Devices > Refractive Eye Surgery Devices Market
Refractive Eye Surgery Devices Market size is forecasted to expand during 2023 and 2032. Refractive surgery is a surgical treatment used to improve vision without the use of eyeglasses by correcting the refractive error of the eye. This technique, which can be done on patients with stable refraction by the ages of 18 to 21, can be categorized as a lens-based surgery and a corneal procedure. The numerous advantages of LASIK refractive surgery for athletes, such as enhanced performance and safety, will contribute to the industry's overall development.
One of the factors driving the market trends for refractive surgical devices is the rising prevalence of uncorrected refractive errors in both children and adults. According to data from the World Health Organization (WHO), almost 2.2 billion individuals globally suffer from near or distant vision impairment, which might increase the expansion for equipment for refractive surgery. The popularity of refractive cataract surgery is expected to increase in the coming years due to the growing prevalence of cataracts among older persons.
Based on the region, The Europe refractive eye surgery devices market to witness strong rise owing to the high demand for ophthalmology services to avoid cases of sight loss in the UK. According to the Royal College of Ophthalmologists, by 2030, sight loss in the nation is anticipated to increase by a third, reaching more than 2.7 million people. Factors like these will have a favorable impact on the refractive surgery centers in the region, as will the rise in the number of Europeans who are in the presbyopia candidate age range.
In terms of product, the refractive eye surgery devices market from the microkeratome segment to generate remarkable revenue growth by 2032. This would be credited to the diverse benefits of the laser vision correction device which include quicker operation and greater patient comfort. Despite these benefits, the adoption of microkeratome devices may be hampered in the years to come by potential issues related to LASIK procedures performed with microkeratomes, such as the hole in the flap and the hazards of a partial flap.
Lensar, Ellex Medical, Lumenis, Avedro (Glaukos Corp.), Bosch + Lomb Surgical, Alcon Laboratories, Zeimer Ophthalmic Systems, Carl Zeiss Meditec Inc., IVIS Technologies, Schwind Eye-Tech-Solutions, and Johnson and Johnson Company are some of the major players in the global refractive surgery devices industry.
New developments in the refractive eye surgery devices market
In a bid to grow business in the international market, companies specializing in refractive eye surgery devices are concentrating on the introduction of new products and engaging in partnerships and acquisitions. For instance, in June 2021, Bausch & Lomb signed a contract with Lochan LLC to upgrade its eyeTELLIGENCE clinical decision support software. The goal behind the creation of this program was to improve efficiency and to give surgeons the ability to seamlessly integrate the processes of refractive, retinal, and cataract surgery.